HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease.

Abstract
Numbers of endothelial progenitor cells (EPCs) have been shown to be decreased in subjects with end-stage renal disease (ESRD), the mechanism of which remained poorly understood. In this study, mutual association among circulating EPC levels, carotid atherosclerosis, serum pentosidine, and skin autofluorescence, a recently established noninvasive measure of advanced glycation end products accumulation, was examined in 212 ESRD subjects undergoing hemodialysis. Numbers of circulating EPCs were measured as CD34+ CD133+ CD45(low) VEGFR2+ cells and progenitor cells as CD34+ CD133+ CD45(low) fraction by flow cytometry. Skin autofluorescence was assessed by the autofluorescence reader; and serum pentosidine, by enzyme-linked immunosorbent assay. Carotid atherosclerosis was determined as intimal-medial thickness (IMT) measured by ultrasound. Circulating EPCs were significantly and inversely correlated with skin autofluorescence in ESRD subjects (R = -0.216, P = .002), but not with serum pentosidine (R = -0.079, P = .25). Circulating EPCs tended to be inversely associated with IMT (R = -0.125, P = .069). Intimal-medial thickness was also tended to be correlated positively with skin autofluorescence (R = 0.133, P = .054) and significantly with serum pentosidine (R = 0.159, P = .019). Stepwise multiple regression analyses reveal that skin autofluorescence, but not serum pentosidine and IMT, was independently associated with low circulating EPCs. Of note, skin autofluorescence was also inversely and independently associated with circulating progenitor cells. Thus, tissue accumulated, but not circulating, advanced glycation end products may be a determinant of a decrease in circulating EPCs in ESRD subjects.
AuthorsHiroki Ueno, Hidenori Koyama, Shinya Fukumoto, Shinji Tanaka, Takuhito Shoji, Tetsuo Shoji, Masanori Emoto, Hideki Tahara, Masaaki Inaba, Ryusuke Kakiya, Tsutomu Tabata, Toshio Miyata, Yoshiki Nishizawa
JournalMetabolism: clinical and experimental (Metabolism) Vol. 60 Issue 4 Pg. 453-9 (Apr 2011) ISSN: 1532-8600 [Electronic] United States
PMID20494372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Cross-Linking Reagents
  • Glycation End Products, Advanced
  • Arginine
  • pentosidine
  • Lysine
Topics
  • Aged
  • Arginine (analogs & derivatives)
  • Carotid Artery Diseases (complications, diagnostic imaging, pathology)
  • Cross-Linking Reagents
  • Endothelial Cells (physiology)
  • Female
  • Flow Cytometry
  • Fluorescence
  • Glycation End Products, Advanced (metabolism)
  • Humans
  • Kidney Failure, Chronic (complications, metabolism, pathology)
  • Lysine (analogs & derivatives)
  • Male
  • Middle Aged
  • Regression Analysis
  • Skin Physiological Phenomena
  • Stem Cells (physiology)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: